Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.

Saved in:
Bibliographic Details
Title: Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.
Authors: Ndiaye BP; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Koech L; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya., Mercer LD; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Aponte JJ; PATH Center for Vaccine Innovation and Access, Geneva, Switzerland., Cisse B; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Riziki F; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya., Keter W; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya., Eaton N; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Diye S; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Wade D; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Bob NS; Institut Pasteur de Dakar, Dakar, Senegal., Raine MG; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Her H; EuBiologics, Seoul, South Korea., Kim S; EuBiologics, Seoul, South Korea., Erdem R; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Lee C; EuBiologics, Seoul, South Korea., Cassels FJ; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Park Y; EuBiologics, Seoul, South Korea., Dia M; Institut Pasteur de Dakar, Dakar, Senegal., Baik YO; EuBiologics, Seoul, South Korea., Fall G; Institut Pasteur de Dakar, Dakar, Senegal., Locke E; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Njuguna PW; PATH Center for Vaccine Innovation and Access, Nairobi, Kenya. Electronic address: pnjuguna@path.org.
Source: The Lancet. Global health [Lancet Glob Health] 2025 Dec; Vol. 13 (12), pp. e2122-e2132.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Equivalence Trial
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41240950
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ndiaye+BP%22">Ndiaye BP</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Koech+L%22">Koech L</searchLink>; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Aponte+JJ%22">Aponte JJ</searchLink>; PATH Center for Vaccine Innovation and Access, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cisse+B%22">Cisse B</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Riziki+F%22">Riziki F</searchLink>; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Keter+W%22">Keter W</searchLink>; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Eaton+N%22">Eaton N</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Diye+S%22">Diye S</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Wade+D%22">Wade D</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Bob+NS%22">Bob NS</searchLink>; Institut Pasteur de Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Raine+MG%22">Raine MG</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Her+H%22">Her H</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Erdem+R%22">Erdem R</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Cassels+FJ%22">Cassels FJ</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Dia+M%22">Dia M</searchLink>; Institut Pasteur de Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Baik+YO%22">Baik YO</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Fall+G%22">Fall G</searchLink>; Institut Pasteur de Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Locke+E%22">Locke E</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Njuguna+PW%22">Njuguna PW</searchLink>; PATH Center for Vaccine Innovation and Access, Nairobi, Kenya. Electronic address: pnjuguna@path.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101613665%22">The Lancet. Global health</searchLink> [Lancet Glob Health] 2025 Dec; Vol. 13 (12), pp. e2122-e2132.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Equivalence Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101613665 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2214-109X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222214109X%22">2214109X </searchLink><i>NLM ISO Abbreviation: </i>Lancet Glob Health <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41240950
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2214-109X(25)00330-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2122
    Titles:
      – TitleFull: Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ndiaye BP
      – PersonEntity:
          Name:
            NameFull: Koech L
      – PersonEntity:
          Name:
            NameFull: Mercer LD
      – PersonEntity:
          Name:
            NameFull: Aponte JJ
      – PersonEntity:
          Name:
            NameFull: Cisse B
      – PersonEntity:
          Name:
            NameFull: Riziki F
      – PersonEntity:
          Name:
            NameFull: Keter W
      – PersonEntity:
          Name:
            NameFull: Eaton N
      – PersonEntity:
          Name:
            NameFull: Diye S
      – PersonEntity:
          Name:
            NameFull: Wade D
      – PersonEntity:
          Name:
            NameFull: Bob NS
      – PersonEntity:
          Name:
            NameFull: Raine MG
      – PersonEntity:
          Name:
            NameFull: Her H
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Erdem R
      – PersonEntity:
          Name:
            NameFull: Lee C
      – PersonEntity:
          Name:
            NameFull: Cassels FJ
      – PersonEntity:
          Name:
            NameFull: Park Y
      – PersonEntity:
          Name:
            NameFull: Dia M
      – PersonEntity:
          Name:
            NameFull: Baik YO
      – PersonEntity:
          Name:
            NameFull: Fall G
      – PersonEntity:
          Name:
            NameFull: Locke E
      – PersonEntity:
          Name:
            NameFull: Njuguna PW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2214-109X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The Lancet. Global health
              Type: main
ResultId 1